2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment

BACKGROUND: Helicobacter pylori (H. pylori) infection is an infectious disease with a prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and gastric cancer. H. pylori eradication treatment can effectively control disease progression and reduce the risk of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liya, Lu, Hong, Song, Zhiqiang, Lyu, Bin, Chen, Ye, Wang, Jiyao, Xia, Jun, Zhao, Zhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106216/
https://www.ncbi.nlm.nih.gov/pubmed/36579940
http://dx.doi.org/10.1097/CM9.0000000000002546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106216/
https://www.ncbi.nlm.nih.gov/pubmed/36579940
http://dx.doi.org/10.1097/CM9.0000000000002546

Ejemplares similares